United States - English - NLM (National Library of Medicine)

aspen global inc. - busulfan (unii: g1ln9045dk) (busulfan - unii:g1ln9045dk) - busulfan 2 mg - myleran (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia. myleran is contraindicated in patients in whom a definitive diagnosis of chronic myelogenous leukemia has not been firmly established. myleran is contraindicated in patients who have previously suffered a hypersensitivity reaction to busulfan or any other component of the preparation.

United States - English - NLM (National Library of Medicine)

woodward pharma services llc - busulfan (unii: g1ln9045dk) (busulfan - unii:g1ln9045dk) - myleran (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia. myleran is contraindicated in patients in whom a definitive diagnosis of chronic myelogenous leukemia has not been firmly established. myleran is contraindicated in patients who have previously suffered a hypersensitivity reaction to busulfan or any other component of the preparation.

United States - English - NLM (National Library of Medicine)

waylis therapeutics llc - busulfan (unii: g1ln9045dk) (busulfan - unii:g1ln9045dk) - myleran (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia. myleran is contraindicated in patients in whom a definitive diagnosis of chronic myelogenous leukemia has not been firmly established. myleran is contraindicated in patients who have previously suffered a hypersensitivity reaction to busulfan or any other component of the preparation.

United States - English - NLM (National Library of Medicine)

time cap laboratories, inc. - ferric pyrophosphate (unii: qk8899250f) (ferric cation - unii:91o4lml611), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rb (hygiene home) australia pty ltd - n-octyl bicycloheptene dicarboximide; piperonyl butoxide; phenothrin 20:80; tetramethrin 20:80 - aerosol - n-octyl bicycloheptene dicarboximide bicyclo active 3.18 g/kg; piperonyl butoxide benzodioxole active 2.17 g/kg; phenothrin 20:80 pyrethroid active 0.25 g/kg; tetramethrin 20:80 pyrethroid active 1.08 g/kg - household insecticide - domestic pest control | garden shed | homestead | houses | outbuildings - ant | carpet beetle | cockroach | crawling insect | flea | fly | flying insect | mosquito | moth | silverfish | spider | adult | adult mosquitoes | ants | argentine ant | cockroachs | ctenocephalides spp. | fleas | flies | ground fleas | large cockroach | mosquitoes | moths | pharaoh ant | silverfish | small cockroach

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - moxidectin; imidacloprid - topical solution/suspension - moxidectin anthelmintic active 10.0 g/l; imidacloprid guanidine active 100.0 g/l - parasiticides - cat - over 4 kg - flea - ctenocephalides spp. | flea allergic dermatitis | heartworm - prevention of | hookworm | hookworm - ancylostoma braziliense | hookworm - ancylostoma tubaeforme | hookworm - uncinaria stenocephala | lungworm - cat | roundworm - toxascaris leonina | roundworm - toxocara cati | aelurostrongylus abstrusus | ancylostoma braziliense | ancylostoma caninum | ascarid | human intestinal roundworm | mature stages of aelurostrongy | to prevent heartworm | toxocara mystax | uncinaria stenocephala

Canada - English - Health Canada

hansamed limited - epinephrine; articaine hydrochloride - solution - 5mcg; 40mg - epinephrine 5mcg; articaine hydrochloride 40mg - local anesthetics

Canada - English - Health Canada

hansamed limited - epinephrine; articaine hydrochloride - solution - 0.01mg; 40mg - epinephrine 0.01mg; articaine hydrochloride 40mg - local anesthetics

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection and caffeine citrate oral solution are indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate injection and caffeine citrate oral solution are contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection and caffeine citrate oral solution are indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate injection and caffeine citrate oral solution are contraindicated in patients who have demonstrated hypersensitivity to any of its components. this leaflet tells you about caffeine citrate oral solution and how to give it to your baby. read the following information before giving this medicine to your baby. completely discuss caffeine citrate with your baby’s doctor. continue to discuss any questions you have about this medicine at your baby’s checkups. after you remove your baby’s dose, throw away the open bottle (vial) and all medicine left in it. use each vial of caffeine citrate oral solution for only one dose. there will be extra medicine left in the vial after one dose is removed. leftover medicine should not be used because caffeine citrate oral solution does not contain preservatives. once the vial is open